Loading...
HER2 amplification in tumors activates PI3K/Akt signaling independent of HER3
Current evidence suggests that HER2-driven tumorigenesis requires HER3. This is likely due to the unique ability of HER3 to activate PI3K/Akt pathway signaling, which is not directly accessible to HER2. By genetic elimination of HER3 or shRNA knockdown of HER3 in HER2-amplified cancer cells, we find...
Na minha lista:
| Udgivet i: | Cancer Res |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6779043/ https://ncbi.nlm.nih.gov/pubmed/29760043 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-18-0430 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|